Colonic ulcer after prolongated administration of Kayexalate® (sodium polystyrene sulfonate) [4];Ulcération colique après administration prolongée de Kayexalate® (polystyrène sulfonate de sodium)

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 3, 2004, Pages 311-313

  Hourseau, Muriel ^a   Lagorce Pages, Christine ^a   Benamouzig, Robert ^a   Tuil, Olivier ^a   Ecomard, Marie Adèle ^a   Zemoura, Leila ^a   Martin, Antoine ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALFACALCIDOL; CALCIDIA; IRBESARTAN; LYSINE ACETYLSALICYLATE; NIFEDIPINE; OMEPRAZOLE; POLYSTYRENESULFONATE SODIUM; SORBITOL; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY FAILURE; LETTER; LONG TERM CARE; MALE; ULCERATIVE COLITIS;

EID: 1942469913     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(04)94927-5     Document Type: Article

References (5)

1. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol 1997;21: 60-9.
2. Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol 2001;25:637-44.
3. Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 1987;101:267-72.
4. Gardiner GW. Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients. Can J Gastroenterol 1997;11:573-7.
5. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 1985;40:111-8.